Is a
Patent attributes
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
Date of Patent
October 12, 2021
Patent Application Number
20190807
Date Filed
August 7, 2019
Patent Citations Received
Patent abstract
The present invention relates to RNAi agents, e.g., double-stranded RNAi agents, targeting the apolipoprotein C3 (APOC3) gene, and methods of using such RNAi agents to inhibit expression of APOC3 and methods of treating subjects having an APOC3 associated disorder, e.g., hypertriglyceridemia.
Timeline
No Timeline data yet.
Further Resources
No Further Resources data yet.